The expression BIRC6 gene in patients with chronic lymphocytic leukemia – a preliminary study

1. Abe S. et al.: Bone marrow cells of mieloblastic syndromes exhibit significant expression of apollon, livin and ILP-2 with reduction after transformation to overt leukemia. Leukaemia Research 2005; 29: 1095-1096.10.1016/j.leukres.2005.02.004Search in Google Scholar

2. Bartke T. et al.:Dual role of BRUCE as an antiapoptotic IAP and a chimeric E2/E3 ubiquitin ligasz. Md Cell 2004; 14: 801-811.10.1016/j.molcel.2004.05.018Search in Google Scholar

3. Bianchini M. et al.: Comparative study of gene expression by cDNA microarray in human colorectal cancer tissues and normal mucosa. Int J Oncol. 2006; 29: 83-94.10.3892/ijo.29.1.83Search in Google Scholar

4. Bielak-Żmijewska A.: Mechanizmy oporności komórek nowotworowych na apoptozę. Problemy Nauk Biologicznych. Kosmos 2003; 52: 157-171.Search in Google Scholar

5. Chen Z. et al.: A human IAP-family gene, apollon, expressed in human brain cancer cells. Biochem Biophys Res Commun. 1999; 264: 847-854.10.1006/bbrc.1999.1585Search in Google Scholar

6. Deveraux Q.L., Reed J.C.: IAP family proteins suppressor of apoptosis. Genes Dev. 1999; 13: 239-252.10.1101/gad.13.3.239Search in Google Scholar

7. Ghavami S. et al.: Apoptosis and cancer: mutations within caspase. J Med Genet 2009; 46: 497-510.10.1136/jmg.2009.066944Search in Google Scholar

8. Giannopoulos K.: Biologia i rokowanie w przewlekłej białaczce limfocytowej. Acta Haematologica Polonica 2010; 3: 433-440.Search in Google Scholar

9. Grzybowska-Izydorczyk O., Smolewski P.: Białka inhibitorowe apoptozy z rodziny inhibitorów apoptozy (IAP) i ich antagoniści: rola biologiczna oraz potencjalne znaczenie w karcinogenezie i celowanej terapii przeciwnowotworowej. Acta Haematologica Polonica 2009; 40: 593-612.Search in Google Scholar

10. Grzybowska-Izydorczyk O., Smolewski P.: Rola białek z rodziny inhibitora apoptozy (IAP) w chorobach rozrostowych układu krwiotwórczego. Postępy Hig Med. Dosw. 2008; 62: 55-63.Search in Google Scholar

11. Guo J. et al.: A preliminary study on the implication of Apaf-1 promoter methylation and the expression of apoptosis inhibitor protein Apollon in adult acute leukaemia. Zhonghua Xue Ye Xue Za Zhi. 2010; 31: 736-739.Search in Google Scholar

12. Ismail EA. Et al.: BIRC6/Apollon gene expression in childhood acute leukemia: impact on therapeutic response and prognosis. Eur J Haematol. 2012; 88:118-27. [53]10.1111/j.1600-0609.2011.01734.xSearch in Google Scholar

13. Kaczmarek-Borowska B., Zmorzyński Sz., Filip A.: Biologiczna rola surwiwiny. Współczesna onkologia 2008; 10: 437-440.Search in Google Scholar

14. Korzeniowska-Dyl I.: Kaspazy - struktura i funkcja. Pol. Merk. Lek. 2007; 138: 403-407.Search in Google Scholar

15. Krawczyk-Kuliś M et al.: Nowe markery prognostyczne przewlekłej białaczki limfocytowej badane metodą immunofenotypizacji. Acta Haematologica Polonica 2012; 3: 271-276.10.1016/S0001-5814(12)34004-8Search in Google Scholar

16. Lewandowski K, Matuszak M.: Czynniki prognostyczne w przewlekłej białaczce limfatycznej B-komórkowej. Współczesna Onkologia, 2003; 7:470-475.Search in Google Scholar

17. Lopergolo A. et al.: Apollon gene silencing induces apoptosis in breast cancer cells through p53 stabilisation and caspase-3 activation. Journal List 2009; 100: 739-746.10.1038/sj.bjc.6604927265377619223905Search in Google Scholar

18. Lotz K., Pyrowolakis G., Jentsch S.: BRUCE, a gigant E2/E3 ubiquitin ligase and inhibitor of apoptosis protein of the trans - Golgi network, is required for normal placenta development and mouse survival. Mol Cell Biol. 2004; 24: 9339-9350. 10.1128/MCB.24.21.9339-9350.200452224715485903Search in Google Scholar

19. Malinowska I.: Rola apoptozy w patogenezie i leczeniu nowotwór układu hematopoetycznego. Postępy Hig Med. Dosw. 2004; 58: 548-559.Search in Google Scholar

20. Mitrus I., Missot-Kolka E., Szala S.: Geny proapoptotyczne w terapii genowej nowotworów. Współczesna onkologia 2001; 5: 242-249.Search in Google Scholar

21. Pohl C., Jentsch S.: Final stages of cytokinesis and mid-body ring formation are controlled by BRUCE. Cell 2008; 132: 832-845.10.1016/j.cell.2008.01.01218329369Search in Google Scholar

22. Qiu X.B. et al.: Nrdpl-mediated degradation of the gigantic IAP, BRUCE, is a novel pathway for triggering apoptosis. EMBO J. 2004; 23: 800-810.10.1038/sj.emboj.760007538099214765125Search in Google Scholar

23. Rumble J.M., Duckett C.S.: Diverse function within the IAP family. Journal of Cell Science 2008; 121: 3505-3507.10.1242/jcs.040303275487118946021Search in Google Scholar

24. Rupniewska Z., Koczkodaj D., Wąsik-Szczepanek E.: BRUCE/ Apollon i jego rola w rodzinie białek hamujących apoptozę. Acta Haematologica Polonica 2006; 37: 329-337.Search in Google Scholar

25. Salilew-Wondim D et al.:. Depletion of BIRC6 leads to retarded bovine early embryonic development and blastocyst formation in vitro. Reprod Fertil Dev. 2010; 22: 564-79.10.1071/RD0911220188030Search in Google Scholar

26. Stańczyk M., Majsterek I.: Apoptoza - cel ukierunkowanej terapii przeciwnowotworowej. Postępy Biologii Komórki, 2008; 35: 467-484.Search in Google Scholar

27. Sung K.W. et al.: Over-expression of Apollon, an antiapoptotic protein is Associated with Poor Prognosis in Childhood De novo Acute Myeloid Leukemia. Clin CANCER Res. 2007; 13: 5109-5114.10.1158/1078-0432.CCR-07-069317785565Search in Google Scholar

28. Verhagen A.M., Coulson E.J., Vaux D.L.: Inhibitor of apoptosis proteins and their relatives: IAPs and other BIRPs. Genome Biology 2001; 2: 3009.1-3009.10.10.1186/gb-2001-2-7-reviews300913942011516343Search in Google Scholar

29. Wright C.W., Duckett C.S.: Reawakening the cellular death program in neoplasia through the therapeutic blockade of IAP. J Clin Invest 2005; 115: 2673-2678.10.1172/JCI26251123669116200201Search in Google Scholar

30. Yamamoto K. et al.: Expression of IAP proteins in myelodysplastic syndromes trans forming to overt leukemia. Leukemia Research 2004; 28: 1203-1211.10.1016/j.leukres.2004.03.02015380346Search in Google Scholar

31. Yang L.Y., Li X.M.: The IAP family: endogenous caspase inhibitors with multiple biological activities. Cell Research 2000; 10: 169-177.10.1038/sj.cr.729004611032169Search in Google Scholar

32. Hao Y., Sekine K., Kawabata A., Nakamura H., Ishoika T., Ohata H., KatayamaR., Hashimoto C., Zhang X., Tsuro T., Kwaito M. Apollon ubiquitinates Smac and caspases-9 and has an essential cytoprotetion function. Nature Cell Biol 2004; 6: abstract.10.1038/ncb115915300255Search in Google Scholar

33. Sekine K., Hao Y., Suzuki Y., Takahashi R., Tsuruo T., Natio M. HtrA2 cleaves Apollon and induces cell death by IAP-binding motif in Apollon-deficient cells. Biochem Biophys Res Commun. 2005; 330: abstract10.1016/j.bbrc.2005.02.16515781261Search in Google Scholar

34. Hauser H.P., Bardoff M., Pyrowolakis G., Jentsch S. A giant ubiquitin-conjugating enzyme related to IAP apoptosis inhibitors. J Cell Biol. 1998;141: abstract. 10.1083/jcb.141.6.141521327959628897Search in Google Scholar